Head-To-Head Comparison: Intuitive Surgical (NASDAQ:ISRG) vs. ReWalk Robotics (NASDAQ:LFWD)

Intuitive Surgical (NASDAQ:ISRG) and ReWalk Robotics (NASDAQ:LFWD) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings and target prices for Intuitive Surgical and ReWalk Robotics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	0	4	13	0	2.76
ReWalk Robotics	0	0	1	0	3.00

Intuitive Surgical presently has a consensus price target of $396.17, indicating a potential upside of 6.58%. ReWalk Robotics has a consensus price target of $9.00, indicating a potential upside of 89.47%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, analysts clearly believe ReWalk Robotics is more favorable than Intuitive Surgical.

Earnings & Valuation

This table compares Intuitive Surgical and ReWalk Robotics’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$7.32 billion	18.02	$1.80 billion	$5.54	67.09
ReWalk Robotics	$13.85 million	2.92	-$22.13 million	($2.87)	-1.66

Intuitive Surgical has higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are owned by institutional investors. 0.9% of Intuitive Surgical shares are owned by company insiders. Comparatively, 2.1% of ReWalk Robotics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Intuitive Surgical has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500.

Profitability

This table compares Intuitive Surgical and ReWalk Robotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	27.16%	12.91%	11.22%
ReWalk Robotics	-159.76%	-28.19%	-23.29%

Summary

Intuitive Surgical beats ReWalk Robotics on 10 of the 14 factors compared between the two stocks.

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.